These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 893245)

  • 21. Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates. Resistance during ciprofloxacin plus rifampin therapy for methicillin-resistant S aureus colonization.
    Peterson LR; Quick JN; Jensen B; Homann S; Johnson S; Tenquist J; Shanholtzer C; Petzel RA; Sinn L; Gerding DN
    Arch Intern Med; 1990 Oct; 150(10):2151-5. PubMed ID: 2222100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-trimoxazole resistant mycobacterium marinum.
    Cunningham MJ; White PM; Samman PD
    Br J Dermatol; 1978 Nov; 99(5):597. PubMed ID: 708634
    [No Abstract]   [Full Text] [Related]  

  • 23. Resistance to co-trimoxazole.
    McAllister TA
    Scand J Infect Dis Suppl; 1976; (8):29-38. PubMed ID: 1084551
    [No Abstract]   [Full Text] [Related]  

  • 24. Phage types and drug susceptibility patterns of Staphylococcus aureus from two hospitals in northwest Ethiopia.
    Truneh M
    Ethiop Med J; 1991 Jan; 29(1):1-6. PubMed ID: 1825811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staphylococcus aureus phage types and their correlation to antibiotic resistance.
    Mehndiratta PL; Gur R; Saini S; Bhalla P
    Indian J Pathol Microbiol; 2010; 53(4):738-41. PubMed ID: 21045404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning and characterization of a novel trimethoprim-resistant dihydrofolate reductase from a nosocomial isolate of Staphylococcus aureus CM.S2 (IMCJ1454).
    Sekiguchi J; Tharavichitkul P; Miyoshi-Akiyama T; Chupia V; Fujino T; Araake M; Irie A; Morita K; Kuratsuji T; Kirikae T
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3948-51. PubMed ID: 16127079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Staphylococcus aureus in the hospital milieu].
    Larabi K; Abouda H; Fendri C; Ben Rachid MS
    Arch Inst Pasteur Tunis; 1992; 69(3-4):283-92. PubMed ID: 1341138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nosocomial infections with the detection of Staphylococcus aureus in an average hospital--an 11-year analysis].
    Heuck D; Dinger E; Voigt M; Claus H; Witte W
    Zentralbl Hyg Umweltmed; 1994 Aug; 196(1):52-69. PubMed ID: 7802897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Letter: Co-trimoxazole resistance.
    Then R; Angehrn P
    Br Med J; 1974 Jan; 1(5897):78-9. PubMed ID: 4590994
    [No Abstract]   [Full Text] [Related]  

  • 30. Multiply-resistant Staphylococcus aureus in a hospital affected by industrial dispute.
    Cooper RG; Coglin MA; Clough R
    Med J Aust; 1987 Nov; 147(9):469. PubMed ID: 3670202
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparison of the antibacterial activity of sulphonamide-trimethoprim combinations.
    Fourie ED; van Straten AM; Maritz HC; van Rensburg AJ
    S Afr Med J; 1979 Mar; 55(14):544-7. PubMed ID: 377523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological analysis of methicillin resistant Staphylococcus aureus in Thailand.
    Wongwanich S; Tishyadhigama P; Paisomboon S; Ohta T; Hayashi H
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):72-6. PubMed ID: 11023068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EMRSA-16: a new epidemic strain of Staphylococcus aureus.
    Commun Dis Rep CDR Wkly; 1993 Feb; 3(6):25. PubMed ID: 9355690
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of cefaclor, phenethicillin, co-trimoxazole and doxycycline on colonization resistance in healthy volunteers.
    Vollaard EJ; Clasener HA; van Griethuysen AJ; Janssen AJ; Sanders-Reijmers AH; Muller NF; Huige PJ
    J Antimicrob Chemother; 1988 Nov; 22(5):747-58. PubMed ID: 3145269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transduction of chloramphenicol resistance determinant by a newly isolated bacteriophage in Staphylococcus aureus.
    Młynarczyk G; Młynarczyk A; Osowiecki H
    Acta Microbiol Pol; 1979; 28(2):101-9. PubMed ID: 89789
    [No Abstract]   [Full Text] [Related]  

  • 36. Letter: Susceptibility of Bacteroides fragilis to co-trimoxazole.
    Okubadejo OA
    Lancet; 1974 May; 1(7865):1061. PubMed ID: 4133750
    [No Abstract]   [Full Text] [Related]  

  • 37. [Characteristics of hospital strains of Staphylococcus].
    Voropaeva SD; Ratgauz GL; Mironova TG; Pashkov EP
    Antibiotiki; 1979 Apr; 24(4):263-7. PubMed ID: 443787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of co-trimoxazole in sulphonamide-resistant Escherichia coli urinary tract infection.
    Grüneberg RN
    J Antimicrob Chemother; 1975 Sep; 1(3):305-10. PubMed ID: 1102516
    [No Abstract]   [Full Text] [Related]  

  • 39. Gentamicin- and methicillin-resistant Staphylococcus aureus: phenotypic and genotypic characterization of three putative nosocomial outbreak strains.
    Traub WH; Leonhard B; Bauer D
    Chemotherapy; 1996; 42(1):21-36. PubMed ID: 8751264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nosocomial infection caused by methicillin-resistant Staphylococcus aureus in Palestine.
    Adwan K; Abu-Hasan N; Adwan G; Jarrar N; Abu-Shanab B; Abu-Zant A
    Microb Drug Resist; 2005; 11(1):75-7. PubMed ID: 15770099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.